Background: Lung adenocarcinoma (LUAD) exhibits pronounced cellular and molecular heterogeneity that shapes tumor progression and therapeutic response. Although nucleotide metabolism is essential for sustaining tumor proliferation and coordinating immune interactions, its single-cell heterogeneity and clinical implications remain incompletely defined. Methods: We integrated a publicly available scRNA-seq dataset derived from independent LUAD patients to construct a comprehensive LUAD cellular atlas, identified malignant epithelial cells using inferCNV, and reconstructed differentiation trajectories via Monocle2. Cell–cell communication patterns under distinct nucleotide metabolic states were assessed using CellChat. A nucleotide metabolism-related signature (NMRS) was subsequently developed across TCGA-LUAD and multiple GEO cohorts using 101 combinations of machine learning algorithms. Its prognostic and immunological predictive value was systematically evaluated. The functional relevance of the key gene ENO1 was further verified through pan-cancer analyses and in vitro experiments. Results: We identified substantial nucleotide metabolic heterogeneity within malignant epithelial cells, closely linked to elevated proliferative activity, glycolytic activation, and increased CNV burden. Pseudotime analysis showed that epithelial cells gradually acquire enhanced immune-modulatory and complement-related functions along their differentiation continuum. High-metabolism epithelial cells exhibited stronger outgoing communication—particularly via MIF, CDH5, and MHC-II pathways—highlighting their potential role in shaping an immunosuppressive microenvironment. The NMRS built from metabolism-related genes provided robust prognostic stratification across multiple cohorts and surpassed conventional clinical parameters. Immune profiling revealed that high-NMRS tumors displayed increased T-cell dysfunction, stronger exclusion, higher TIDE scores, and lower IPS, suggesting poorer responses to immune checkpoint blockade. ENO1, markedly upregulated in high-NMRS tumors and functioning as a risk factor in several cancer types, was experimentally shown to promote invasion in LUAD cell lines. Conclusions: This study delineates the profound impact of nucleotide metabolic reprogramming on epithelial cell states, immune ecology, and malignant evolution in LUAD. The NMRS provides a robust predictor of prognosis and immunotherapy response across cohorts, while ENO1 emerges as a pivotal metabolic–immune mediator and promising therapeutic target.
Background: Cellular senescence and the senescence-associated secretory phenotype (SASP) can alter communication between tumor cells and the surrounding microenvironment, but the extracellular mediators involved in this process remain poorly defined in lung adenocarcinoma (LUAD). Methods: Bulk transcriptomic analysis was used to characterize senescence-related transcriptional alterations and construct a prognostic signature. ANGPTL4 expression was evaluated in public datasets and clinical samples. Single-cell RNA-sequencing analysis was then performed to map senescence-associated gene-set scores across LUAD cell populations and to examine the cell–cell communication. ANGPTL4 depletion and overexpression were used to assess its effects on LUAD-cell proliferation, migration, and SA-β-gal positivity, while a subcutaneous xenograft model was used to examine tumor growth in vivo. Conditioned-medium and indirect co-culture experiments were performed to assess the effects of ANGPTL4-overexpressing LUAD cells on THP-1-derived macrophage inflammatory responses, and MCC950 was used to evaluate the contribution of NLRP3-associated signaling. Results: Senescence-related transcriptional alterations in LUAD were enriched in inflammatory and immune-related pathways. ANGPTL4 was included in a five-gene prognostic model and selected for functional investigation because it encodes a secreted protein. We found that ANGPTL4 protein levels were increased in LUAD tissues. Single-cell analysis showed relatively high senescence-associated gene-set scores in macrophage-enriched populations, together with stronger cell–cell communication in the higher-score group. ANGPTL4 depletion reduced LUAD-cell migration and SA-β-gal positivity, while its overexpression had the opposite effects and resulted in larger xenograft tumors. Conditioned medium and indirect co-culture experiments showed that ANGPTL4-overexpressing LUAD cells induced inflammatory changes in THP-1-derived macrophages, accompanied by increased NLRP3-associated markers and IL-1β secretion. These changes were partly attenuated by MCC950. Conclusions: These findings suggest that ANGPTL4 is associated with tumor cell–macrophage crosstalk in LUAD and may correlate with senescence-related transcriptional signatures, while the specific biological role of ANGPTL4 remains to be further characterized.